 |
|
Predictors of Preclinical Alzheimer Disease and Dementia
A Clinicopathologic Study
James E. Galvin, MD, MPH;
Kimberly K. Powlishta, PhD;
Kenneth Wilkins, MD;
Daniel W. McKeel, Jr, MD;
Chengjie Xiong, PhD;
Elizabeth Grant, PhD;
Martha Storandt, PhD;
John C. Morris, MD
Arch Neurol. 2005;62:758-765.
Background To understand the earliest signs of cognitive decline caused by Alzheimer disease (AD) and other illnesses causing dementia, information is needed from well-characterized individuals without dementia studied longitudinally until autopsy.
Objective To determine clinical and cognitive features associated with the development of AD or other dementias in older adults.
Design Longitudinal study of memory and aging.
Setting Alzheimer’s Disease Research Center, St Louis, Mo.
Main Outcome Measures Clinical Dementia Rating, its sum of boxes, and neuropathologic diagnosis of dementia.
Participants Eighty control participants who eventually came to autopsy.
Results Individuals who did not develop dementia showed stable cognitive performance. Entry predictors of dementia were age, deficits in problem solving as well as memory, slowed psychomotor performance, and depressive features. Minimal cognitive decline occurred prior to dementia diagnosis, after which sharp decline was noted. Even individuals who were minimally cognitively impaired (Clinical Dementia Rating = 0.5) typically had neuropathologic AD at autopsy. Histopathologic AD also was present in 34% of individuals who did not have dementia at death; these individuals without dementia showed an absence of practice effects on cognitive testing.
Conclusions Increased age, depressive features, and even minimal cognitive impairment, as determined clinically by Clinical Dementia Rating sum of boxes and by slowed psychomotor performance, identify older individuals without dementia who develop dementia. Older adults who do not develop dementia have stable cognitive performance. The absence of practice effects may denote the subset of older adults without dementia with histopathologic AD, which may reflect a preclinical stage of the illness.
Author Affiliations: Departments of Neurology (Drs Galvin, Wilkins, and Morris), Anatomy and Neurobiology (Dr Galvin), Psychology (Dr Powlishta and Storandt), and Pathology and Immunology (Drs McKeel and Morris), Division of Biostatistics (Drs Xiong and Grant), Alzheimer’s Disease Research Center (Drs Galvin, Powlishta, Wilkins, McKeel, Xiong, Grant, Storandt, and Morris), School of Medicine, Washington University, St Louis, Mo. Dr Powlishta is now with the Department of Psychology, Saint Louis University, and Dr Wilkins is now with the Department of Family Medicine, Saint Louis University School of Medicine, St Louis.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
Sojkova et al.
JNM 2008;49:1465-1471.
ABSTRACT
| FULL TEXT
Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia
Olichney et al.
Neurology 2008;70:1763-1770.
ABSTRACT
| FULL TEXT
Brain Volume Decline in Aging: Evidence for a Relation Between Socioeconomic Status, Preclinical Alzheimer Disease, and Reserve
Fotenos et al.
Arch Neurol 2008;65:113-120.
ABSTRACT
| FULL TEXT
Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment
Dickerson et al.
Arch Gen Psychiatry 2007;64:1443-1450.
ABSTRACT
| FULL TEXT
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
Goodenowe et al.
J. Lipid Res. 2007;48:2485-2498.
ABSTRACT
| FULL TEXT
Dissociation of Neuropathologic Findings and Cognition: Case Report of an Apolipoprotein E {varepsilon}2/{varepsilon}2 Genotype
Berlau et al.
Arch Neurol 2007;64:1193-1196.
ABSTRACT
| FULL TEXT
Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment
Perneczky et al.
J Geriatr Psychiatry Neurol 2007;20:84-88.
ABSTRACT
Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease
Galvin et al.
Neurology 2007;68:1895-1901.
ABSTRACT
| FULL TEXT
Evaluation of Cognitive Impairment in Older Adults: Combining Brief Informant and Performance Measures
Galvin et al.
Arch Neurol 2007;64:718-724.
ABSTRACT
| FULL TEXT
Preclinical Vascular Cognitive Impairment and Alzheimer Disease: Neuropsychological Test Performance 5 Years Before Diagnosis
Ingles et al.
Stroke 2007;38:1148-1153.
ABSTRACT
| FULL TEXT
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
Williams et al.
Neurology 2006;67:1935-1941.
ABSTRACT
| FULL TEXT
Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research
Kuller
J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:1314-1318.
ABSTRACT
| FULL TEXT
Clinical phenotype of Parkinson disease dementia.
Galvin et al.
Neurology 2006;67:1605-1611.
ABSTRACT
| FULL TEXT
Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline
Boyle et al.
Neurology 2006;67:441-445.
ABSTRACT
| FULL TEXT
Alzheimer neuropathology in nondemented aging: Keeping mind over matter
Lippa and Morris
Neurology 2006;66:1801-1802.
FULL TEXT
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett et al.
Neurology 2006;66:1837-1844.
ABSTRACT
| FULL TEXT
|
